Woodline Partners LP Boosts Stake in Intuitive Surgical, Inc. (NASDAQ:ISRG)

Woodline Partners LP raised its position in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) by 27.0% during the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 82,889 shares of the medical equipment provider's stock after acquiring an additional 17,640 shares during the period. Woodline Partners LP's holdings in Intuitive Surgical were worth $43,265,000 as of its most recent filing with the Securities & Exchange Commission.

Other hedge funds have also bought and sold shares of the company. Atala Financial Inc bought a new position in Intuitive Surgical during the fourth quarter valued at $25,000. Hurley Capital LLC bought a new position in Intuitive Surgical during the fourth quarter valued at $28,000. Berbice Capital Management LLC bought a new position in Intuitive Surgical during the fourth quarter valued at $26,000. Parvin Asset Management LLC bought a new position in Intuitive Surgical during the fourth quarter valued at $26,000. Finally, BankPlus Trust Department bought a new position in Intuitive Surgical during the fourth quarter valued at $28,000. Institutional investors own 83.64% of the company's stock.

Intuitive Surgical Stock Down 0.8%

NASDAQ:ISRG traded down $4.40 during mid-day trading on Thursday, reaching $542.67. The company's stock had a trading volume of 1,128,016 shares, compared to its average volume of 1,644,782. Intuitive Surgical, Inc. has a 1 year low of $396.15 and a 1 year high of $616.00. The stock has a fifty day moving average of $510.44 and a 200-day moving average of $537.67. The firm has a market capitalization of $194.50 billion, a PE ratio of 84.66, a price-to-earnings-growth ratio of 5.85 and a beta of 1.70.

Intuitive Surgical (NASDAQ:ISRG - Get Free Report) last released its quarterly earnings results on Tuesday, April 22nd. The medical equipment provider reported $1.81 EPS for the quarter, beating the consensus estimate of $1.71 by $0.10. The business had revenue of $2.25 billion during the quarter, compared to analyst estimates of $2.19 billion. Intuitive Surgical had a net margin of 27.81% and a return on equity of 14.55%. During the same period in the prior year, the firm posted $1.50 earnings per share. On average, analysts expect that Intuitive Surgical, Inc. will post 6.43 earnings per share for the current year.

Insider Buying and Selling at Intuitive Surgical

In other Intuitive Surgical news, EVP Robert Desantis sold 11,545 shares of the stock in a transaction dated Thursday, March 13th. The shares were sold at an average price of $499.22, for a total transaction of $5,763,494.90. Following the completion of the sale, the executive vice president now directly owns 5,224 shares of the company's stock, valued at approximately $2,607,925.28. This represents a 68.85% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which can be accessed through this hyperlink. Also, EVP Myriam Curet sold 2,401 shares of the stock in a transaction dated Thursday, February 27th. The shares were sold at an average price of $581.00, for a total transaction of $1,394,981.00. Following the sale, the executive vice president now directly owns 353 shares of the company's stock, valued at approximately $205,093. The trade was a 87.18% decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 32,700 shares of company stock valued at $16,865,621. 0.70% of the stock is currently owned by insiders.

Wall Street Analysts Forecast Growth

ISRG has been the subject of a number of recent analyst reports. CICC Research initiated coverage on shares of Intuitive Surgical in a research note on Monday, January 27th. They set a "neutral" rating and a $550.00 target price for the company. Royal Bank of Canada lowered their target price on shares of Intuitive Surgical from $630.00 to $605.00 and set an "outperform" rating for the company in a research note on Wednesday, April 23rd. Erste Group Bank lowered shares of Intuitive Surgical from a "strong-buy" rating to a "hold" rating in a research note on Monday, March 17th. Piper Sandler lowered their target price on shares of Intuitive Surgical from $670.00 to $575.00 and set an "overweight" rating for the company in a research note on Wednesday, April 23rd. Finally, Robert W. Baird lowered their target price on shares of Intuitive Surgical from $600.00 to $575.00 and set an "outperform" rating for the company in a research note on Wednesday, April 23rd. Five equities research analysts have rated the stock with a hold rating and fifteen have given a buy rating to the stock. According to MarketBeat, the company currently has a consensus rating of "Moderate Buy" and an average price target of $596.05.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.